Use of PEA and Scutellaria in Synergy With Therapeutic Exercise in Chemotherapy-induced Peripheral Neuropathy (CIPN): a Clinical Trial

This study aims to find out if taking specific dietary supplements (PEA and Scutellaria) along with therapeutic exercise can help reduce nerve pain and damage caused by chemotherapy. Many cancer patients experience nerve-related side effects from chemotherapy, which can significantly impact their quality of life. The study will observe patients who use these supplements and exercises to see if they can effectively manage and improve their nerve health and reduce pain.

NCT Number	NCT07352514
Lead Sponsor	University of Palermo
Conditions	Chemotherapy-induced Peripheral Neuropathy (CIPN), Neuropathic Pain
Enrollment	40 participants
Start Date	2025-03-15
Primary Completion	2026-02-20 (estimated)
Study Completion	2026-04 (estimated)
Updated on ClinicalTrials.gov	2026-01-20